Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Respiratory Sinus Arrhythmia Attenuation via Targeted Lung Denervation in Sheep and Humans.

Valipour A, Mayse ML, Peterson AD, Johnson PJ, Rouw KT, Asadi S, Hummel JP.

Respiration. 2019 Sep 13:1-6. doi: 10.1159/000501623. [Epub ahead of print]

2.

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe COPD (AIRFLOW): A Multicenter Randomized Controlled Trial.

Slebos DJ, Shah PL, Herth FJ, Pison C, Schumann C, Hübner RH, Bonta PI, Kessler R, Gesierich W, Darwiche K, Lamprecht B, Perez T, Skowasch D, Deslee G, Marceau A, Sciurba FC, Gosens R, Hartman JE, Srikanthan K, Duller M, Valipour A; AIRFLOW-2 Trial Study Group.

Am J Respir Crit Care Med. 2019 Aug 12. doi: 10.1164/rccm.201903-0624OC. [Epub ahead of print]

PMID:
31404499
3.

Treatment of ALK-rearranged non-small-cell lung cancer with brigatinib as second or later lines: real-world observations from a single institution.

Hochmair M, Weinlinger C, Schwab S, Naber J, Setinek U, Krenbek D, Urban MH, Fabikan H, Watzka S, Koger R, Fazekas A, Bitterlich E, Valipour A, Burghuber OC.

Anticancer Drugs. 2019 Aug;30(7):e0787. doi: 10.1097/CAD.0000000000000787.

PMID:
31305295
4.

Safety and Dose Study of Targeted Lung Denervation in Moderate/Severe COPD Patients.

Valipour A, Shah PL, Pison C, Ninane V, Janssens W, Perez T, Kessler R, Deslee G, Garner J, Abele C, Hartman JE, Slebos DJ; On behalf of the AIRFLOW-1 Study Group.

Respiration. 2019 Jun 20:1-11. doi: 10.1159/000500463. [Epub ahead of print]

5.

Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study.

Miravitlles M, Koblizek V, Esquinas C, Milenkovic B, Barczyk A, Tkacova R, Somfay A, Zykov K, Tudoric N, Kostov K, Zbozinkova Z, Svoboda M, Sorli J, Krams A, Valipour A.

Respir Med. 2019 Apr;150:141-148. doi: 10.1016/j.rmed.2019.03.007. Epub 2019 Mar 21.

PMID:
30961941
6.

Effectiveness of phase- and morphology-controlled MnO2 nanomaterials derived from flower-like δ-MnO2 as alternative cathode catalyst in microbial fuel cells.

Valipour A, Hamnabard N, Meshkati SMH, Pakan M, Ahn YH.

Dalton Trans. 2019 Apr 16;48(16):5429-5443. doi: 10.1039/c9dt00520j.

PMID:
30951077
7.

Endoscopic Lung Volume Reduction: An Expert Panel Recommendation - Update 2019.

Herth FJF, Slebos DJ, Criner GJ, Valipour A, Sciurba F, Shah PL.

Respiration. 2019;97(6):548-557. doi: 10.1159/000496122. Epub 2019 Mar 5.

PMID:
30836374
8.

Basic Occupational Health Services for Agricultural Workers in the South of Iran.

Tabibi R, Tarahomi S, Ebrahimi SM, Valipour AA, Ghorbani-Kalkhajeh S, Tajzadeh S, Panahi D, Soltani S, Dzhsupov KO, Sokooti M.

Ann Glob Health. 2018 Aug 31;84(3):465-469. doi: 10.29024/aogh.2312.

9.

The Effect of Different Intensities of Static Magnetic Field on Stress and Selected Reproductive Indices of the Zebrafish (Danio rerio) During Acute and Subacute Exposure.

Sedigh E, Heidari B, Roozati A, Valipour A.

Bull Environ Contam Toxicol. 2019 Feb;102(2):204-209. doi: 10.1007/s00128-018-02538-1. Epub 2019 Jan 9.

PMID:
30627748
10.
11.

Long-term safety of bilateral targeted lung denervation in patients with COPD.

Valipour A, Asadi S, Pison C, Jondot M, Kessler R, Benneddif K, Deslee G, Verdier M, Slebos DJ, Mayse M.

Int J Chron Obstruct Pulmon Dis. 2018 Jul 16;13:2163-2172. doi: 10.2147/COPD.S158748. eCollection 2018.

12.

Bronchoscopic Thermal Vapor Ablation: Best Practice Recommendations from an Expert Panel on Endoscopic Lung Volume Reduction.

Gompelmann D, Shah PL, Valipour A, Herth FJF.

Respiration. 2018;95(6):392-400. doi: 10.1159/000489815. Epub 2018 Jun 12. Review.

13.

Phenotypes of COPD in an Austrian population : National data from the POPE study.

Reiger G, Zwick R, Lamprecht B, Kähler C, Burghuber OC, Valipour A.

Wien Klin Wochenschr. 2018 Jun;130(11-12):382-389. doi: 10.1007/s00508-018-1347-7. Epub 2018 May 24.

PMID:
29797071
14.

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

Brcic L, Stanzer S, Krenbek D, Gruber-Moesenbacher U, Absenger G, Quehenberger F, Valipour A, Lindenmann J, Stoeger H, Al Effah M, Fediuk M, Balic M, Popper HH.

Virchows Arch. 2018 Apr;472(4):589-598. doi: 10.1007/s00428-018-2326-0. Epub 2018 Mar 8.

15.

Cardiorespiratory system monitoring using a developed acoustic sensor.

Abbasi-Kesbi R, Valipour A, Imani K.

Healthc Technol Lett. 2018 Jan 12;5(1):7-12. doi: 10.1049/htl.2017.0012. eCollection 2018 Feb.

16.

The effect of education on the nursing care quality of patients who are under mechanical ventilation in ICU ward.

Geravandi S, Soltani F, Mohammadi MJ, Alizadeh R, Valipour A, Hoseini A, Rastegarimehr B, Yari AR, Karimyan A, Ghomeishi A.

Data Brief. 2017 Dec 6;16:822-827. doi: 10.1016/j.dib.2017.11.090. eCollection 2018 Feb.

17.

Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.

Ariel A, Altraja A, Belevskiy A, Boros PW, Danila E, Fležar M, Koblizek V, Fridlender ZG, Kostov K, Krams A, Milenkovic B, Somfay A, Tkacova R, Tudoric N, Ulmeanu R, Valipour A.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 21;13:45-56. doi: 10.2147/COPD.S145573. eCollection 2018. Review.

18.

Forecasting the Incidence of Testis Cancer in Europe from 2012-2035.

Valipour AA, Mohammadian M, Mohammadian-Hafshejani A, Islamie Farsani S.

Iran J Public Health. 2017 Oct;46(10):1448-1449. No abstract available.

19.

The Future Prospects of Testis Cancer in the World.

Ghafari M, Mohammadian M, Valipour AA, Mohammadian-Hafshejani A.

Iran J Public Health. 2017 Dec;46(12):1750-1751. No abstract available.

20.

The relationship between knowledge of leadership and knowledge management practices in the food industry in Kurdistan province, Iran.

Jad SMM, Geravandi S, Mohammadi MJ, Alizadeh R, Sarvarian M, Rastegarimehr B, Afkar A, Yari AR, Momtazan M, Valipour A, Mahboubi M, Karimyan A, Mazraehkar A, Nejad AS, Mohammadi H.

Data Brief. 2017 Sep 22;15:155-159. doi: 10.1016/j.dib.2017.09.031. eCollection 2017 Dec.

21.

[Test Your Knowledge].

Firlinger I, Frischer T, Valipour A.

Pneumologie. 2017 Nov;71(11):718-721. doi: 10.1055/s-0043-119597. Epub 2017 Nov 13. German. No abstract available.

PMID:
29139099
22.

[Test Your Knowledge].

Valipour A.

Pneumologie. 2017 Aug;71(8):505-507. doi: 10.1055/s-0043-106527. Epub 2017 Aug 7. German. No abstract available.

PMID:
28783862
23.

Risk factors accelerating hypothyroidism in pregnant women referred to health centers in Abadan, Iran.

Momtazan M, Mohammadi MJ, Tabahfar R, Rezaee S, Valipour A, Jamei F, Yari AR, Karimyan A, Geravandi S.

Data Brief. 2017 Jul 14;14:15-19. doi: 10.1016/j.dib.2017.07.013. eCollection 2017 Oct.

24.

Bi-amino surface functionalized polyoxometalate nanocomposite as an environmentally friendly catalyst: synthesis and dye degradation.

Mahmoodi NM, Oveisi M, Alina Asli M, Rezvani MA, Valipour A.

Water Sci Technol. 2017 May;75(10):2381-2389. doi: 10.2166/wst.2017.131.

PMID:
28541946
25.

Predict the Future Incidence and Mortality of Breast Cancer in Iran from 2012-2035.

Valipour AA, Mohammadian M, Ghafari M, Mohammadian-Hafshejani A.

Iran J Public Health. 2017 Apr;46(4):579-580. No abstract available.

26.

Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study.

Koblizek V, Milenkovic B, Barczyk A, Tkacova R, Somfay A, Zykov K, Tudoric N, Kostov K, Zbozinkova Z, Svancara J, Sorli J, Krams A, Miravitlles M, Valipour A.

Eur Respir J. 2017 May 11;49(5). pii: 1601446. doi: 10.1183/13993003.01446-2016. Print 2017 May.

27.

GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort.

Tudoric N, Koblizek V, Miravitlles M, Valipour A, Milenkovic B, Barczyk A, Somfay A, Zykov K, Kostov K, Zbozinkova Z, Svoboda M, Sorli J, Krams A, Tkacova R.

Eur Respir J. 2017 Apr 26;49(4). pii: 1602518. doi: 10.1183/13993003.02518-2016. Print 2017 Apr. No abstract available.

28.

[Test Your Knowledge].

Valipour A.

Pneumologie. 2017 Mar;71(3):143-145. doi: 10.1055/s-0043-102550. Epub 2017 Mar 20. German. No abstract available.

PMID:
28320036
29.

Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD.

Urban MH, Eickhoff P, Funk GC, Burghuber OC, Wolzt M, Valipour A.

Int J Chron Obstruct Pulmon Dis. 2017 Jan 4;12:169-176. doi: 10.2147/COPD.S118596. eCollection 2017.

30.

Physical Activity and Colorectal Cancer.

Ghafari M, Mohammadian M, Valipour AA, Mohammadian-Hafshejani A.

Iran J Public Health. 2016 Dec;45(12):1673-1674. No abstract available.

31.

First use of Amplatzer device for bronchopleural fistula after lung transplantation.

Gómez López A, García Luján R, De Pablo Gafas A, Hernández Hernández F, Villena Garrido V, Valipour A, Meneses Pardo JC, De Miguel Poch E.

Thorax. 2017 Jul;72(7):668-670. doi: 10.1136/thoraxjnl-2016-209543. Epub 2017 Jan 2. No abstract available.

PMID:
28044004
32.

Some Facts on Problematic Internet Use and Sleep Disturbance among Adolescents.

Islamie Farsani S, Allahbakhshi K, Valipour AA, Mohammadian-Hafshejani A.

Iran J Public Health. 2016 Nov;45(11):1531-1532. No abstract available.

33.

Endobronchial Valves for Endoscopic Lung Volume Reduction: Best Practice Recommendations from Expert Panel on Endoscopic Lung Volume Reduction.

Slebos DJ, Shah PL, Herth FJ, Valipour A.

Respiration. 2017;93(2):138-150. doi: 10.1159/000453588. Epub 2016 Dec 20. Review.

34.

How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?

Beeh KM, Burgel PR, Franssen FME, Lopez-Campos JL, Loukides S, Hurst JR, Fležar M, Ulrik CS, Di Marco F, Stolz D, Valipour A, Casserly B, Ställberg B, Kostikas K, Wedzicha JA.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):139-149. doi: 10.1164/rccm.201609-1794CI. Review.

35.

Bronchoscopic Thermal Vapour Ablation: Hot Stuff to Treat Emphysema Patients!

Valipour A.

Arch Bronconeumol. 2017 Jan;53(1):1-2. doi: 10.1016/j.arbres.2016.08.012. Epub 2016 Dec 2. English, Spanish. No abstract available.

36.

Lung Volume Reduction with Vapor Ablation in the Presence of Incomplete Fissures: 12-Month Results from the STEP-UP Randomized Controlled Study.

Gompelmann D, Eberhardt R, Schuhmann M, Valipour A, Shah PL, Herth FJ, Kontogianni K.

Respiration. 2016;92(6):397-403. Epub 2016 Nov 12.

37.

[Test Your Knowledge].

Valipour A.

Pneumologie. 2016 Nov;70(11):697-698. Epub 2016 Nov 9. German. No abstract available.

PMID:
27829253
38.
39.

Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study.

Valipour A, Slebos DJ, Herth F, Darwiche K, Wagner M, Ficker JH, Petermann C, Hubner RH, Stanzel F, Eberhardt R; IMPACT Study Team.

Am J Respir Crit Care Med. 2016 Nov 1;194(9):1073-1082.

PMID:
27580428
40.

Endoscopic valve therapy for emphysema: Patient selection as the Holy Grail to success.

Valipour A.

Respirology. 2016 Oct;21(7):1148-9. doi: 10.1111/resp.12876. Epub 2016 Aug 22. No abstract available.

41.

Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results.

Shah PL, Gompelmann D, Valipour A, McNulty WH, Eberhardt R, Grah C, Egan J, Ficker JH, Wagner M, Witt C, Liebers U, Hopkins P, Gesierich W, Phillips M, Stanzel F, Petermann C, Strange C, Snell G, Herth FJF.

Lancet Respir Med. 2016 Sep;4(9):e44-e45. doi: 10.1016/S2213-2600(16)30199-0. Epub 2016 Jul 20. No abstract available.

PMID:
27451345
42.

POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe.

Zbozinkova Z, Barczyk A, Tkacova R, Valipour A, Tudoric N, Zykov K, Somfay A, Miravitlles M, Koblizek V.

Int J Chron Obstruct Pulmon Dis. 2016 Mar 22;11:611-22. doi: 10.2147/COPD.S88846. eCollection 2016.

43.

[Test Your Knowledge].

Frasnelli C, Valipour A.

Pneumologie. 2016 Mar;70(3):149-50. doi: 10.1055/s-0042-101113. Epub 2016 Mar 15. German. No abstract available.

PMID:
26977752
44.

Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial.

Herth FJ, Valipour A, Shah PL, Eberhardt R, Grah C, Egan J, Ficker JH, Wagner M, Witt C, Liebers U, Hopkins P, Gesierich W, Phillips M, Stanzel F, McNulty WH, Petermann C, Snell G, Gompelmann D.

Lancet Respir Med. 2016 Mar;4(3):185-93. doi: 10.1016/S2213-2600(16)00045-X. Epub 2016 Feb 16.

PMID:
26899390
45.

Layer-by-layer assembly of gold nanoparticles and cysteamine on gold electrode for immunosensing of human chorionic gonadotropin at picogram levels.

Roushani M, Valipour A, Valipour M.

Mater Sci Eng C Mater Biol Appl. 2016 Apr 1;61:344-50. doi: 10.1016/j.msec.2015.12.088. Epub 2015 Dec 30.

PMID:
26838859
46.

[Test Your Knowledge].

Kemetzhofer E, Valipour A.

Pneumologie. 2016 Jan;70(1):15-6. doi: 10.1055/s-0041-110100. Epub 2016 Jan 20. German. No abstract available.

PMID:
26789427
47.

Constructed wetlands as sustainable ecotechnologies in decentralization practices: a review.

Valipour A, Ahn YH.

Environ Sci Pollut Res Int. 2016 Jan;23(1):180-97. doi: 10.1007/s11356-015-5713-y. Epub 2015 Nov 3. Review.

PMID:
26527342
48.

[Semen analysis in involuntary childlessness. What information does it provide?].

Weberschock T, Valipour A, Ochsendorf F.

Hautarzt. 2015 Dec;66(12):924-32. doi: 10.1007/s00105-015-3707-9. Review. German.

PMID:
26452353
49.

Patterns of Emphysema Heterogeneity.

Valipour A, Shah PL, Gesierich W, Eberhardt R, Snell G, Strange C, Barry R, Gupta A, Henne E, Bandyopadhyay S, Raffy P, Yin Y, Tschirren J, Herth FJ.

Respiration. 2015;90(5):402-11. doi: 10.1159/000439544. Epub 2015 Oct 3.

50.

Genetic Variants of Cytochrome b-245, Alpha Polypeptide Gene and Premature Acute Myocardial Infarction Risk in an Iranian Population.

Amin F, Jahani MM, Ghaedi H, Alipoor B, Fatemi A, Tajik M, Sharifi Z, Golmohammadi T, Askari M, Azarnejad A, Alipoor S, Valipour A, Mousavizadeh K.

J Med Biochem. 2015 Oct;34(4):402-408. doi: 10.2478/jomb-2014-0066. Epub 2015 Sep 19.

Supplemental Content

Loading ...
Support Center